Elutia Inc.
ELUT Healthcare Medical Devices
In the quarter to June 2026, revenue fell 11.7%, EPS grew 26.1% and free cash flow fell 2.52%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow ELUT
Elutia Inc. (ELUT) EV/Sales
As of 16 October 2026, Elutia Inc. (ELUT) trades at a EV/Sales of 3.4×. Over the past ten years it has ranged from 0.0× (December 2020) to 16.6× (July 2025); the current reading is higher than 56% of that period. That is above the Medical Devices industry median of 2.2× and in line with the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.5× | (81.92%) |
| FY2024 | 8.2× | 309.87% |
| FY2023 | 2.0× | (36.71%) |
| FY2022 | 3.2× | 179.89% |
| FY2021 | 1.1× | (56.94%) |
| FY2020 | 2.6× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 4.1× | 18.92% |
| Mar 2026 | 3.4× | 130.23% |
| Dec 2025 | 1.5× | (82.75%) |
| Sep 2025 | 8.6× | (37.52%) |
| 22 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| ITOC iTonic Holdings Ltd. compare | n/m |
| NSYS Nortech Systems Incorporated compare | 0.2× |
| NNOX Nano-X Imaging Ltd. compare | 0.4× |
| XTNT Xtant Medical Holdings, Inc. compare | 0.5× |
| CVRX CVRx, Inc. compare | 0.5× |
| RPID Rapid Micro Biosystems, Inc. compare | 1.0× |
| SNWV Sanuwave Health Inc. compare | 1.2× |
| QTI QT Imaging Holdings, Inc. compare | 1.5× |
| ELUT Elutia Inc. | 3.4× |
| Medical Devices industry median | 2.2× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)